This Solicitation opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
CLOBETASOL PROPIONATE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract involves the procurement of Clobetasol Propionate Lotion and Cream, 0.05%, in 15-gram tubes, under solicitation SPE2DP-26-T-4161, issued by the Department of Defense through the Defense Logistics Agency’s Medical Supply Chain, Pharm FSA. The delivery is required within five calendar days of award to Fort Stewart, Georgia, under FOB Destination terms, meaning the contractor bears all transportation costs and risks until delivery is completed. The unit of issue is TU, with a total quantity of four TUs, each equivalent to three individual tubes, and no variance in quantity is permitted. The item is regulated by the FDA, and bidders must provide manufacturer details, including NDC numbers for approved products such as Teva Pharmaceuticals, Taro Pharmaceuticals, and Avkare LLC, with specific references to GLAXO SMITH KLINE’s TEMOVATE. The contract mandates packaging and marking per MIL-STD-2073-1E and Medical Marking Standard No. 1, which supersedes MIL-STD-129 for general marking but retains MIL-STD-129 for hazardous materials labeling. All packaging must protect against damage and be suitable for commercial carrier shipment at the lowest cost, with export packaging required when applicable. The product has a non-extendable shelf life of 18 months (Type I, Code K), and contractors must comply with the DLA Master List of Technical and Quality Requirements, including RA001 and RS013, while ensuring full adherence to FDA and OSHA regulations for labeling and hazard communication. The contract incorporates numerous FAR and DFARS clauses related to employment equity, trafficking in persons, cybersecurity safeguarding, hazardous material identification, subcontracting, and supply chain security, including mandatory implementation of NIST SP 800-171 and reporting of cyber incidents under 252.204-7012. Invoicing must be submitted via WAWF, and the government will inspect and accept the product at the point of delivery. Offerors must hold and provide current UEI and CAGE codes, represent their size status and socioeconomic certifications such as WOSB, SDVOSB, or HUBZone, and disclose any involvement withcovered defense telecommunications equipment. The solicitation does not specify a contract type, pricing, or evaluation factors, and award is likely based on a lowest price technically acceptable approach within a simplified acquisition framework. All
General Info
Agency
NAICS
Place of Performance
BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
CLOBETASOL PROPIONATE CREAM,0.05%,15 GM TUBE
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
GLAXO SMITH KLINE "TEMOVATE" NDC00173-0375-73
TEVA PHARM NDC51672-1258-01
AAC L; U/I "TU" (15 GM)
MGAC, LFLYNN 06054
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 TU = 3 EA
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SPE2DP-26-T-4161
SECTION B
RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a shelf life of 18 months (non-extendable) applies to this item.
TARO PHARMACEUTICALS U.S.A., INC. 3HFB6 P/N NDC51622-1258-01 AVKARE LLC 4QGW8 P/N NDC42291-0076-15 TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC51672-1258-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017505604 0001 TU 4.000
NSN/MATERIAL:6505012299098
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-229-9098 Quantity: 4 TU Purchase Request: 7017505604QTY: 4 Delivery: 5 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS